TY - BOOK AU - Dunn, J. AU - Watson, M. PY - 2016 DA - 2016// TI - Aitken JF PB - Hyde MK CY - Systematic Review of Psychosocial Outcomes for Patients with Advanced Melanoma. Psychooncology ID - Dunn2016 ER - TY - JOUR AU - Park, S. M. AU - Li, T. AU - Wu, S. AU - Li, W. Q. AU - Weinstock, M. AU - Qureshi, A. A. AU - Cho, E. PY - 2017 DA - 2017// TI - Niacin intake and risk of skin cancer in US women and men JO - Int J Cancer VL - 140 UR - https://doi.org/10.1002/ijc.30630 DO - 10.1002/ijc.30630 ID - Park2017 ER - TY - STD TI - Loquai C, Schmidtmann I, Garzarolli M, Kaatz M, Kahler KC, Kurschat P, Meiss F, Micke O, Muecke R, Muenstedt K, et al. Interactions from complementary and alternative medicine in patients with melanoma. Melanoma Res. 2017; in press ID - ref3 ER - TY - JOUR AU - Chhabra, A. AU - Mukherji, B. AU - Batra, D. PY - 2017 DA - 2017// TI - Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53 JO - Expert Opin Ther Targets VL - 21 UR - https://doi.org/10.1080/14728222.2017.1270941 DO - 10.1080/14728222.2017.1270941 ID - Chhabra2017 ER - TY - JOUR AU - Polkowska, M. AU - Czepielewska, E. AU - Kozlowska-Wojciechowska, M. PY - 2016 DA - 2016// TI - Drug combinations as the new standard for melanoma treatment JO - Curr Treat Options in Oncol VL - 17 UR - https://doi.org/10.1007/s11864-016-0436-y DO - 10.1007/s11864-016-0436-y ID - Polkowska2016 ER - TY - JOUR AU - Madeddu, C. AU - Dessi, M. AU - Panzone, F. AU - Serpe, R. AU - Antoni, G. AU - Cau, M. C. AU - Montaldo, L. AU - Mela, Q. AU - Mura, M. AU - Astara, G. PY - 2012 DA - 2012// TI - Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib +/− megestrol acetate for patients with cancer-related anorexia/cachexia syndrome JO - Clin Nutr VL - 31 UR - https://doi.org/10.1016/j.clnu.2011.10.005 DO - 10.1016/j.clnu.2011.10.005 ID - Madeddu2012 ER - TY - STD TI - Li Z, Ye S, OuYang L, Zhang H, Chen Y, He J, Chen Q, Qian C, Zhang X, Cui J, et al: COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells. Oncoimmunology 2015, 4:e1044712. eCollection. ID - ref7 ER - TY - JOUR AU - Guo, Z. AU - Jiang, J. AU - Zhang, J. AU - Yang, H. AU - Yang, F. AU - Qi, Y. AU - Zhong, Y. AU - Su, J. AU - Yang, R. AU - Li, L. AU - Xiang, B. PY - 2015 DA - 2015// TI - COX-2 promotes migration and invasion by the side population of cancer stem cell-like hepatocellular carcinoma cells JO - Medicine VL - 94 UR - https://doi.org/10.1097/MD.0000000000001806 DO - 10.1097/MD.0000000000001806 ID - Guo2015 ER - TY - JOUR AU - Cao, C. AU - Gao, R. AU - Zhang, M. AU - Amelio, A. L. AU - Fallahi, M. AU - Chen, Z. AU - Gu, Y. AU - Hu, C. AU - Welsh, E. A. AU - Engel, B. E. PY - 2015 DA - 2015// TI - Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer JO - J Natl Cancer Inst VL - 107 UR - https://doi.org/10.1093/jnci/dju358 DO - 10.1093/jnci/dju358 ID - Cao2015 ER - TY - JOUR AU - Kim, K. M. AU - Im, A. AU - Kim, S. H. AU - Hyun, J. W. AU - Chae, S. PY - 2016 DA - 2016// TI - Timosaponin AIII inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasis JO - Cancer Sci VL - 107 UR - https://doi.org/10.1111/cas.12852 DO - 10.1111/cas.12852 ID - Kim2016 ER - TY - JOUR AU - Goulet, A. C. AU - Einsphar, J. G. AU - Alberts, D. S. AU - Beas, A. AU - Burk, C. AU - Bhattacharyya, A. AU - Bangert, J. AU - Harmon, J. M. AU - Fujiwara, H. AU - Koki, A. AU - Nelson, M. A. PY - 2003 DA - 2003// TI - Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression JO - Cancer Biol Ther VL - 2 UR - https://doi.org/10.4161/cbt.2.6.627 DO - 10.4161/cbt.2.6.627 ID - Goulet2003 ER - TY - JOUR AU - Panza, E. AU - Cicco, P. AU - Ercolano, G. AU - Armogida, C. AU - Scognamiglio, G. AU - Anniciello, A. M. AU - Botti, G. AU - Cirino, G. AU - Ianaro, A. PY - 2016 DA - 2016// TI - Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.10976 DO - 10.18632/oncotarget.10976 ID - Panza2016 ER - TY - JOUR AU - Szymanski, P. T. AU - Muley, P. AU - Ahmed, S. A. AU - Khalifa, S. AU - Fahmy, H. PY - 2012 DA - 2012// TI - Sarcophine-diol inhibits expression of COX-2, inhibits activity of cPLA2, enhances degradation of PLA2 and PLC(gamma)1 and inhibits cell membrane permeability in mouse melanoma B16F10 cells JO - Mar Drugs VL - 10 UR - https://doi.org/10.3390/md10102166 DO - 10.3390/md10102166 ID - Szymanski2012 ER - TY - JOUR AU - Adler, N. R. AU - Haydon, A. AU - McLean, C. A. AU - Kelly, J. W. AU - Mar, V. J. PY - 2017 DA - 2017// TI - Metastatic pathways in patients with cutaneous melanoma JO - Pigment Cell Melanoma Res VL - 30 UR - https://doi.org/10.1111/pcmr.12544 DO - 10.1111/pcmr.12544 ID - Adler2017 ER - TY - JOUR AU - El-Rayes, B. F. AU - Zalupski, M. M. AU - Shields, A. F. AU - Ferris, A. M. AU - Vaishampayan, U. AU - Heilbrun, L. K. AU - Venkatramanamoorthy, R. AU - Adsay, V. AU - Philip, P. A. PY - 2005 DA - 2005// TI - A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer JO - Invest New Drug VL - 23 UR - https://doi.org/10.1007/s10637-005-1028-z DO - 10.1007/s10637-005-1028-z ID - El-Rayes2005 ER - TY - JOUR AU - Elmets, C. A. AU - Viner, J. L. AU - Pentland, A. P. AU - Cantrell, W. AU - Lin, H. AU - Bailey, H. AU - Kang, S. AU - Linden, K. G. AU - Heffernan, M. AU - Duvic, M. PY - 2010 DA - 2010// TI - Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial JO - J Natl Cancer Inst VL - 102 UR - https://doi.org/10.1093/jnci/djq442 DO - 10.1093/jnci/djq442 ID - Elmets2010 ER - TY - JOUR AU - Javle, M. M. AU - Cao, S. AU - Durrani, F. A. AU - Pendyala, L. AU - Lawrence, D. D. AU - Smith, P. F. AU - Creaven, P. J. AU - Noel, D. C. AU - Iyer, R. V. AU - Rustum, Y. M. PY - 2007 DA - 2007// TI - Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracil JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-0551 DO - 10.1158/1078-0432.CCR-06-0551 ID - Javle2007 ER - TY - JOUR AU - Seo, K. W. AU - Coh, Y. R. AU - Rebhun, R. B. AU - Ahn, J. O. AU - Han, S. M. AU - Lee, H. W. AU - Youn, H. Y. PY - 2014 DA - 2014// TI - Antitumor effects of celecoxib in COX-2 expressing and non-expressing canine melanoma cell lines JO - Res Vet Sci VL - 96 UR - https://doi.org/10.1016/j.rvsc.2014.03.003 DO - 10.1016/j.rvsc.2014.03.003 ID - Seo2014 ER - TY - JOUR AU - Sadhu, S. S. AU - Wang, S. AU - Averineni, R. K. AU - Seefeldt, T. AU - Yang, Y. AU - Guan, X. PY - 2016 DA - 2016// TI - In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine JO - Melanoma Res VL - 26 UR - https://doi.org/10.1097/CMR.0000000000000291 DO - 10.1097/CMR.0000000000000291 ID - Sadhu2016 ER - TY - JOUR AU - Gowda, R. AU - Sharma, A. AU - Robertson, G. P. PY - 2017 DA - 2017// TI - Synergistic inhibitory effects of celecoxib and Plumbagin on melanoma tumor growth JO - Cancer Lett VL - 385 UR - https://doi.org/10.1016/j.canlet.2016.10.016 DO - 10.1016/j.canlet.2016.10.016 ID - Gowda2017 ER - TY - STD TI - Niessner H, Sinnberg T, Kosnopfel C, Smalley KSM, Beck D, Praetorius C, Mai M, Beissert S, Kulms D, Schaller M, et al. BRAF inhibitors amplify the pro-apoptotic activity of MEK inhibitors by inducing ER stress in NRAS-mutant melanoma. Clin Cancer Res. 2017; https://doi.org/10.1158/1078-0432.CCR-17-0098. in press. in press. ID - ref21 ER - TY - JOUR AU - Escuin-Ordinas, H. AU - Atefi, M. AU - Fu, Y. AU - Cass, A. AU - Ng, C. AU - Huang, R. R. AU - Yashar, S. AU - Comin-Anduix, B. AU - Avramis, E. AU - Cochran, A. J. PY - 2014 DA - 2014// TI - COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors JO - Mol Oncol VL - 8 UR - https://doi.org/10.1016/j.molonc.2013.11.005 DO - 10.1016/j.molonc.2013.11.005 ID - Escuin-Ordinas2014 ER - TY - JOUR AU - Guo, H. AU - Ma, Y. AU - Zhang, B. AU - Sun, B. AU - Niu, R. AU - Ying, G. AU - Zhang, N. PY - 2009 DA - 2009// TI - Pivotal advance: PKC zeta is required for migration of macrophages JO - J Leukoc Biol VL - 85 UR - https://doi.org/10.1189/jlb.0708429 DO - 10.1189/jlb.0708429 ID - Guo2009 ER - TY - JOUR AU - Sun, R. H. AU - Gao, P. AU - Chen, L. AU - Ma, D. L. AU - Wang, J. M. AU - Oppenheim, J. J. AU - Zhang, N. PY - 2005 DA - 2005// TI - Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-1163 DO - 10.1158/0008-5472.CAN-04-1163 ID - Sun2005 ER - TY - JOUR AU - Schondorf, T. AU - Kurbacher, C. M. AU - Becker, M. AU - Warm, M. AU - Kolhagen, H. AU - Gohring, U. J. PY - 2001 DA - 2001// TI - Heterogeneity of proteinkinase C activity and PKC-zeta expression in clinical breast carcinomas JO - Clin Exp Med VL - 1 UR - https://doi.org/10.1007/PL00012236 DO - 10.1007/PL00012236 ID - Schondorf2001 ER - TY - JOUR AU - Guo, H. AU - Gu, F. AU - Li, W. AU - Zhang, B. AU - Niu, R. AU - Fu, L. AU - Zhang, N. AU - Ma, Y. PY - 2009 DA - 2009// TI - Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells JO - J Neurochem VL - 109 UR - https://doi.org/10.1111/j.1471-4159.2009.05946.x DO - 10.1111/j.1471-4159.2009.05946.x ID - Guo2009 ER - TY - JOUR AU - Liu, Y. AU - Wang, B. AU - Wang, J. AU - Wan, W. AU - Sun, R. AU - Zhao, Y. AU - Zhang, N. PY - 2009 DA - 2009// TI - Down-regulation of PKCzeta expression inhibits chemotaxis signal transduction in human lung cancer cells JO - Lung Cancer VL - 63 UR - https://doi.org/10.1016/j.lungcan.2008.05.010 DO - 10.1016/j.lungcan.2008.05.010 ID - Liu2009 ER - TY - JOUR AU - Krasagakis, K. AU - Fimmel, S. AU - Genten, D. AU - Eberle, J. AU - Quas, P. AU - Ziegler, W. AU - Haller, H. AU - Orfanos, C. E. PY - 2002 DA - 2002// TI - Lack of protein kinase C (PKC)-beta and low PKC-alpha, −delta, −epsilon, and -zeta isozyme levels in proliferating human melanoma cells JO - Int J Oncol VL - 20 ID - Krasagakis2002 ER - TY - JOUR AU - Certa, U. AU - Seiler, M. AU - Padovan, E. AU - Spagnoli, G. C. PY - 2002 DA - 2002// TI - Interferon-a sensitivity in melanoma cells: detection of potential response marker genes JO - Recent Results Cancer Res VL - 160 UR - https://doi.org/10.1007/978-3-642-59410-6_12 DO - 10.1007/978-3-642-59410-6_12 ID - Certa2002 ER - TY - JOUR AU - Oka, M. AU - Kikkawa, U. PY - 2005 DA - 2005// TI - Protein kinase C in melanoma JO - Cancer Metastasis Rev VL - 24 UR - https://doi.org/10.1007/s10555-005-1578-8 DO - 10.1007/s10555-005-1578-8 ID - Oka2005 ER - TY - JOUR AU - Tsubaki, M. AU - Matsuoka, H. AU - Yamamoto, C. AU - Kato, C. AU - Ogaki, M. AU - Satou, T. AU - Itoh, T. AU - Kusunoki, T. AU - Tanimori, Y. AU - Nishida, S. PY - 2007 DA - 2007// TI - The protein kinase C inhibitor, H7, inhibits tumor cell invasion and metastasis in mouse melanoma via suppression of ERK1/2 JO - Clin Exp Metastasis VL - 24 UR - https://doi.org/10.1007/s10585-007-9080-z DO - 10.1007/s10585-007-9080-z ID - Tsubaki2007 ER - TY - JOUR AU - Hodgson, L. AU - Henderson, A. J. AU - Dong, C. PY - 2003 DA - 2003// TI - Melanoma cell migration to type IV collagen requires activation of NF-kappaB JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206059 DO - 10.1038/sj.onc.1206059 ID - Hodgson2003 ER - TY - JOUR AU - Wu, J. AU - Liu, S. AU - Fan, Z. AU - Zhang, L. AU - Tian, Y. AU - Yang, R. PY - 2016 DA - 2016// TI - A novel and selective inhibitor of PKC zeta potently inhibits human breast cancer metastasis in vitro and in mice JO - Tumor Biol VL - 37 UR - https://doi.org/10.1007/s13277-015-4744-9 DO - 10.1007/s13277-015-4744-9 ID - Wu2016 ER - TY - JOUR AU - Wu, J. AU - Zhang, B. AU - Wu, M. AU - Li, H. AU - Niu, R. AU - Ying, G. AU - Zhang, N. PY - 2010 DA - 2010// TI - Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis JO - Invest New Drug VL - 28 UR - https://doi.org/10.1007/s10637-009-9242-8 DO - 10.1007/s10637-009-9242-8 ID - Wu2010 ER - TY - JOUR AU - Li, H. AU - Wu, J. AU - Ying, G. AU - Chen, L. AU - Lai, L. AU - Liu, Z. AU - Zhang, N. AU - Guo, H. PY - 2012 DA - 2012// TI - J-4: a novel and typical preclinical anticancer drug targeting protein kinase C zeta JO - Anti-Cancer Drug VL - 23 UR - https://doi.org/10.1097/CAD.0b013e3283514cc1 DO - 10.1097/CAD.0b013e3283514cc1 ID - Li2012 ER - TY - JOUR AU - Lu, S. AU - Smith, A. P. AU - Moore, D. AU - Lee, N. M. PY - 2010 DA - 2010// TI - Different real-time PCR systems yield different gene expression values JO - Mol Cell Probes VL - 24 UR - https://doi.org/10.1016/j.mcp.2010.04.002 DO - 10.1016/j.mcp.2010.04.002 ID - Lu2010 ER - TY - JOUR AU - Duary, R. K. AU - Bhausaheb, M. A. AU - Batish, V. K. AU - Grover, S. PY - 2012 DA - 2012// TI - Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic lactobacillus plantarum Lp91 in colitis mouse model JO - Mol Biol Rep VL - 39 UR - https://doi.org/10.1007/s11033-011-1269-1 DO - 10.1007/s11033-011-1269-1 ID - Duary2012 ER - TY - JOUR AU - Chang, M. S. AU - Choi, M. J. AU - Park, S. Y. AU - Park, S. K. PY - 2010 DA - 2010// TI - Inhibitory effects of Hoelen extract on Melanogenesis in B16/F1 melanoma cells JO - Phytother Res VL - 24 UR - https://doi.org/10.1002/ptr.3123 DO - 10.1002/ptr.3123 ID - Chang2010 ER - TY - JOUR AU - Zhang, N. AU - Fu, J. AU - Chou, T. PY - 2016 DA - 2016// TI - Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method JO - Am J Cancer Res VL - 6 ID - Zhang2016 ER - TY - JOUR AU - Hussain, S. AU - Assender, J. W. AU - Bond, M. AU - Wong, L. F. AU - Murphy, D. AU - Newby, A. C. PY - 2002 DA - 2002// TI - Activation of protein kinase Czeta is essential for cytokine-induced metalloproteinase-1, −3, and −9 secretion from rabbit smooth muscle cells and inhibits proliferation JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M111890200 DO - 10.1074/jbc.M111890200 ID - Hussain2002 ER - TY - JOUR AU - Goichberg, P. AU - Kalinkovich, A. AU - Borodovsky, N. AU - Tesio, M. AU - Petit, I. AU - Nagler, A. AU - Hardan, I. AU - Lapidot, T. PY - 2006 DA - 2006// TI - cAMP-induced PKCzeta activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-03-0941 DO - 10.1182/blood-2005-03-0941 ID - Goichberg2006 ER - TY - JOUR AU - Wang, Z. AU - Chen, J. AU - Wang, J. AU - Ahn, S. AU - Li, C. AU - Lu, Y. AU - Loveless, V. S. AU - Dalton, J. T. AU - Miller, D. D. AU - Li, W. PY - 2012 DA - 2012// TI - Novel tubulin polymerization inhibitors overcome multidrug resistance and reduce melanoma lung metastasis JO - Pharm Res-Dordr VL - 29 UR - https://doi.org/10.1007/s11095-012-0726-4 DO - 10.1007/s11095-012-0726-4 ID - Wang2012 ER - TY - JOUR AU - Amarzguioui, M. AU - Peng, Q. AU - Wiiger, M. T. AU - Vasovic, V. AU - Babaie, E. AU - Holen, T. AU - Nesland, J. M. AU - Prydz, H. PY - 2006 DA - 2006// TI - Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-2482 DO - 10.1158/1078-0432.CCR-05-2482 ID - Amarzguioui2006 ER - TY - JOUR AU - Bell, E. AU - Ponthan, F. AU - Whitworth, C. AU - Tweddle, D. A. AU - Lunec, J. AU - Redfern, C. P. F. PY - 2014 DA - 2014// TI - COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib JO - Clin Exp Metastas VL - 31 UR - https://doi.org/10.1007/s10585-014-9656-3 DO - 10.1007/s10585-014-9656-3 ID - Bell2014 ER - TY - JOUR AU - Kim, S. H. AU - Kim, Y. AU - Kim, M. AU - Kim, D. S. AU - Lee, S. C. AU - Chi, S. AU - Lee, D. H. AU - Park, S. G. AU - Park, B. C. AU - Bae, K. AU - Kang, S. PY - 2009 DA - 2009// TI - Comparative proteomic analysis of mouse melanoma cell line B16, a metastatic descendant B16F10, and B16 overexpressing the metastasis-associated tyrosine phosphatase PRL-3 JO - Oncol Res VL - 17 UR - https://doi.org/10.3727/096504009789745494 DO - 10.3727/096504009789745494 ID - Kim2009 ER -